Exposure-related interstitial lung disease

Exposure-related interstitial lung disease (also known as extrinsic or environmental interstitial lung disease) refers to a group of lung disorders caused by the inhalation of various harmful substances, including organic dusts, inorganic dusts, chemicals, fumes, and other environmental or occupational agents. These exposures trigger inflammatory and fibrotic processes within the lung interstitium — the tissue and space surrounding the air sacs (alveoli) — leading to progressive scarring and impaired gas exchange. The disease primarily affects the respiratory system, though systemic symptoms may also occur depending on the causative agent. Key clinical features include progressive shortness of breath (dyspnea), chronic dry cough, fatigue, and reduced exercise tolerance. In advanced cases, patients may develop respiratory failure, pulmonary hypertension, and digital clubbing. Specific subtypes within this category include hypersensitivity pneumonitis (caused by organic antigens such as mold or bird proteins), asbestosis, silicosis, coal workers' pneumoconiosis, and other pneumoconioses. The clinical presentation, imaging findings, and prognosis vary depending on the specific exposure, its duration, and intensity. Management centers on identifying and eliminating the causative exposure, which is the most critical step in halting disease progression. Pharmacological treatment may include corticosteroids and immunosuppressive agents, particularly in cases with significant inflammation such as hypersensitivity pneumonitis. Antifibrotic therapies may be considered in cases with progressive fibrosis. Supportive care includes supplemental oxygen therapy, pulmonary rehabilitation, and in severe end-stage disease, lung transplantation may be considered. Regular monitoring with pulmonary function tests and high-resolution CT imaging is essential for tracking disease progression.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Exposure-related interstitial lung disease